_version_ 1784647852463489024
author Ulrich, Lorenz
Halwe, Nico Joel
Taddeo, Adriano
Ebert, Nadine
Schön, Jacob
Devisme, Christelle
Trüeb, Bettina Salome
Hoffmann, Bernd
Wider, Manon
Fan, Xiaoyu
Bekliz, Meriem
Essaidi-Laziosi, Manel
Schmidt, Marie Luisa
Niemeyer, Daniela
Corman, Victor Max
Kraft, Anna
Godel, Aurélie
Laloli, Laura
Kelly, Jenna N.
Calderon, Brenda M.
Breithaupt, Angele
Wylezich, Claudia
Berenguer Veiga, Inês
Gultom, Mitra
Osman, Sarah
Zhou, Bin
Adea, Kenneth
Meyer, Benjamin
Eberhardt, Christiane S.
Thomann, Lisa
Gsell, Monika
Labroussaa, Fabien
Jores, Jörg
Summerfield, Artur
Drosten, Christian
Eckerle, Isabella Anne
Wentworth, David E.
Dijkman, Ronald
Hoffmann, Donata
Thiel, Volker
Beer, Martin
Benarafa, Charaf
author_facet Ulrich, Lorenz
Halwe, Nico Joel
Taddeo, Adriano
Ebert, Nadine
Schön, Jacob
Devisme, Christelle
Trüeb, Bettina Salome
Hoffmann, Bernd
Wider, Manon
Fan, Xiaoyu
Bekliz, Meriem
Essaidi-Laziosi, Manel
Schmidt, Marie Luisa
Niemeyer, Daniela
Corman, Victor Max
Kraft, Anna
Godel, Aurélie
Laloli, Laura
Kelly, Jenna N.
Calderon, Brenda M.
Breithaupt, Angele
Wylezich, Claudia
Berenguer Veiga, Inês
Gultom, Mitra
Osman, Sarah
Zhou, Bin
Adea, Kenneth
Meyer, Benjamin
Eberhardt, Christiane S.
Thomann, Lisa
Gsell, Monika
Labroussaa, Fabien
Jores, Jörg
Summerfield, Artur
Drosten, Christian
Eckerle, Isabella Anne
Wentworth, David E.
Dijkman, Ronald
Hoffmann, Donata
Thiel, Volker
Beer, Martin
Benarafa, Charaf
author_sort Ulrich, Lorenz
collection PubMed
description Emerging variants of concern (VOCs) are driving the COVID-19 pandemic(1,2). Experimental assessments of replication and transmission of major VOCs and progenitors are needed to understand the mechanisms of replication and transmission of VOCs(3). Here we show that the spike protein (S) from Alpha (also known as B.1.1.7) and Beta (B.1.351) VOCs had a greater affinity towards the human angiotensin-converting enzyme 2 (ACE2) receptor than that of the progenitor variant S(D614G) in vitro. Progenitor variant virus expressing S(D614G) (wt-S(614G)) and the Alpha variant showed similar replication kinetics in human nasal airway epithelial cultures, whereas the Beta variant was outcompeted by both. In vivo, competition experiments showed a clear fitness advantage of Alpha over wt-S(614G) in ferrets and two mouse models—the substitutions in S were major drivers of the fitness advantage. In hamsters, which support high viral replication levels, Alpha and wt-S(614G) showed similar fitness. By contrast, Beta was outcompeted by Alpha and wt-S(614G) in hamsters and in mice expressing human ACE2. Our study highlights the importance of using multiple models to characterize fitness of VOCs and demonstrates that Alpha is adapted for replication in the upper respiratory tract and shows enhanced transmission in vivo in restrictive models, whereas Beta does not overcome Alpha or wt-S(614G) in naive animals.
format Online
Article
Text
id pubmed-8828469
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88284692022-02-22 Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta Ulrich, Lorenz Halwe, Nico Joel Taddeo, Adriano Ebert, Nadine Schön, Jacob Devisme, Christelle Trüeb, Bettina Salome Hoffmann, Bernd Wider, Manon Fan, Xiaoyu Bekliz, Meriem Essaidi-Laziosi, Manel Schmidt, Marie Luisa Niemeyer, Daniela Corman, Victor Max Kraft, Anna Godel, Aurélie Laloli, Laura Kelly, Jenna N. Calderon, Brenda M. Breithaupt, Angele Wylezich, Claudia Berenguer Veiga, Inês Gultom, Mitra Osman, Sarah Zhou, Bin Adea, Kenneth Meyer, Benjamin Eberhardt, Christiane S. Thomann, Lisa Gsell, Monika Labroussaa, Fabien Jores, Jörg Summerfield, Artur Drosten, Christian Eckerle, Isabella Anne Wentworth, David E. Dijkman, Ronald Hoffmann, Donata Thiel, Volker Beer, Martin Benarafa, Charaf Nature Article Emerging variants of concern (VOCs) are driving the COVID-19 pandemic(1,2). Experimental assessments of replication and transmission of major VOCs and progenitors are needed to understand the mechanisms of replication and transmission of VOCs(3). Here we show that the spike protein (S) from Alpha (also known as B.1.1.7) and Beta (B.1.351) VOCs had a greater affinity towards the human angiotensin-converting enzyme 2 (ACE2) receptor than that of the progenitor variant S(D614G) in vitro. Progenitor variant virus expressing S(D614G) (wt-S(614G)) and the Alpha variant showed similar replication kinetics in human nasal airway epithelial cultures, whereas the Beta variant was outcompeted by both. In vivo, competition experiments showed a clear fitness advantage of Alpha over wt-S(614G) in ferrets and two mouse models—the substitutions in S were major drivers of the fitness advantage. In hamsters, which support high viral replication levels, Alpha and wt-S(614G) showed similar fitness. By contrast, Beta was outcompeted by Alpha and wt-S(614G) in hamsters and in mice expressing human ACE2. Our study highlights the importance of using multiple models to characterize fitness of VOCs and demonstrates that Alpha is adapted for replication in the upper respiratory tract and shows enhanced transmission in vivo in restrictive models, whereas Beta does not overcome Alpha or wt-S(614G) in naive animals. Nature Publishing Group UK 2021-12-22 2022 /pmc/articles/PMC8828469/ /pubmed/34937050 http://dx.doi.org/10.1038/s41586-021-04342-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ulrich, Lorenz
Halwe, Nico Joel
Taddeo, Adriano
Ebert, Nadine
Schön, Jacob
Devisme, Christelle
Trüeb, Bettina Salome
Hoffmann, Bernd
Wider, Manon
Fan, Xiaoyu
Bekliz, Meriem
Essaidi-Laziosi, Manel
Schmidt, Marie Luisa
Niemeyer, Daniela
Corman, Victor Max
Kraft, Anna
Godel, Aurélie
Laloli, Laura
Kelly, Jenna N.
Calderon, Brenda M.
Breithaupt, Angele
Wylezich, Claudia
Berenguer Veiga, Inês
Gultom, Mitra
Osman, Sarah
Zhou, Bin
Adea, Kenneth
Meyer, Benjamin
Eberhardt, Christiane S.
Thomann, Lisa
Gsell, Monika
Labroussaa, Fabien
Jores, Jörg
Summerfield, Artur
Drosten, Christian
Eckerle, Isabella Anne
Wentworth, David E.
Dijkman, Ronald
Hoffmann, Donata
Thiel, Volker
Beer, Martin
Benarafa, Charaf
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
title Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
title_full Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
title_fullStr Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
title_full_unstemmed Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
title_short Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
title_sort enhanced fitness of sars-cov-2 variant of concern alpha but not beta
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828469/
https://www.ncbi.nlm.nih.gov/pubmed/34937050
http://dx.doi.org/10.1038/s41586-021-04342-0
work_keys_str_mv AT ulrichlorenz enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT halwenicojoel enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT taddeoadriano enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT ebertnadine enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT schonjacob enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT devismechristelle enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT truebbettinasalome enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT hoffmannbernd enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT widermanon enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT fanxiaoyu enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT beklizmeriem enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT essaidilaziosimanel enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT schmidtmarieluisa enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT niemeyerdaniela enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT cormanvictormax enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT kraftanna enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT godelaurelie enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT lalolilaura enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT kellyjennan enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT calderonbrendam enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT breithauptangele enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT wylezichclaudia enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT berenguerveigaines enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT gultommitra enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT osmansarah enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT zhoubin enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT adeakenneth enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT meyerbenjamin enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT eberhardtchristianes enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT thomannlisa enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT gsellmonika enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT labroussaafabien enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT joresjorg enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT summerfieldartur enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT drostenchristian enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT eckerleisabellaanne enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT wentworthdavide enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT dijkmanronald enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT hoffmanndonata enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT thielvolker enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT beermartin enhancedfitnessofsarscov2variantofconcernalphabutnotbeta
AT benarafacharaf enhancedfitnessofsarscov2variantofconcernalphabutnotbeta